SparingVision

Lead Investors

Jeito Capital, UPMC Enterprises

대륙

Europe

법인설립년도

2016

산업

Healthtech

Biotechnology

서비스 소개

SparingVision is a biotechnology company focused development of genomic medicines for the treatment of blinding inherited retinal di

순번

81

지역

Paris, Ile-de-France, France

최근 투자규모(달러환율 적용)

$79.39M

최종 투자규모(달러환율적용)

투자 단계

Series B